<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Computing</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6FF7A8E1-62E2-42C1-9502-44CECFDEB57C"><gtr:id>6FF7A8E1-62E2-42C1-9502-44CECFDEB57C</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>McKenna</gtr:surname><gtr:orcidId>0000-0003-0530-2035</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BCEAAB24-3548-4BAB-970C-463BC316CA93"><gtr:id>BCEAAB24-3548-4BAB-970C-463BC316CA93</gtr:id><gtr:firstName>Fergus Neil</gtr:firstName><gtr:surname>Doubal</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1F960947-3F12-4A52-ABD9-AE2A6E6609E4"><gtr:id>1F960947-3F12-4A52-ABD9-AE2A6E6609E4</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:otherNames>Surendra</gtr:otherNames><gtr:surname>Doney</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1D986E04-33B6-4F3B-A131-F4033334A48D"><gtr:id>1D986E04-33B6-4F3B-A131-F4033334A48D</gtr:id><gtr:firstName>Baljean</gtr:firstName><gtr:surname>Dhillon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3F80F013-4083-41DC-A241-BB6959CDACAB"><gtr:id>3F80F013-4083-41DC-A241-BB6959CDACAB</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>J.</gtr:otherNames><gtr:surname>Deary</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D3AD31AD-7CBD-4EA4-8B8F-81BFC4E7C55E"><gtr:id>D3AD31AD-7CBD-4EA4-8B8F-81BFC4E7C55E</gtr:id><gtr:firstName>Emanuele</gtr:firstName><gtr:surname>Trucco</gtr:surname><gtr:orcidId>0000-0002-5055-0794</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/070AF2F0-F5AE-4A96-B29B-FE72A23E1FF5"><gtr:id>070AF2F0-F5AE-4A96-B29B-FE72A23E1FF5</gtr:id><gtr:firstName>Joanna</gtr:firstName><gtr:surname>Wardlaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C5C6A6BA-C654-4ADE-9399-6DD7CE375AC2"><gtr:id>C5C6A6BA-C654-4ADE-9399-6DD7CE375AC2</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>Joseph</gtr:otherNames><gtr:surname>MacGillivray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FM005976%2F1"><gtr:id>22ACA477-6936-4DEF-B94B-9DF357616B7B</gtr:id><gtr:title>Multi-modal retinal biomarkers for vascular dementia: developing enabling image analysis tools</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/M005976/1</gtr:grantReference><gtr:abstractText>Dementia is a devastating disease. It has catastrophic implications for affected individuals, their family, wider society, and heavy, increasing costs for the NHS. Detecting subjects at increased risk of developing dementia in the future, and detecting adverse risk at the earliest stages of dementia, may present opportunities to preserve brain function and delay disease progression. 

There is increasing recognition that degeneration of brain blood vessels plays a role in the development of dementia. It is therefore important to identify patients likely to present such degeneration as early as possible, as they may require special treatment and the disease progress can be delayed.

There is also strong clinical evidence that the brain blood vessels are related to those in the retina, the part of the eye responsible for the first stage of human vision. The retina is checked routinely by high-street opticians, hence retinal images (fundus photography and optical coherence tomography, now both available on a single device) could provide an inexpensive, non-invasive procedure capable of capturing early signs of dementia or those at high risk of developing dementia. It would exploit widely available existing examinations and be deployable immediately. Hence the potential impact of a retinal test for dementia signs would be huge. 

The central question is whether the retina can provide (a) reliable biomarkers (signs) for future risk of dementia, and (b) sensitive biomarkers of disease progression of either cognitive decline or brain vessels degeneration. Our purpose is to develop enabling technologies based on image analysis to identify such biomarkers, using easily accessible retinal features (supporting an uninvasive, inexpensive, easily accessible and high-specificity test), and joint brain-retina features (a larger-scope investigation motivated by the affinity of small vessels of brain and retina). 

We shall validate the technologies in a pilot study in collaboration with the specialist units at the University Hospitals of Dundee and Edinburgh, including ophthalmology, brain imaging, and cognitive ageing and cognitive epidemiology. Our research is supported by the Alzheimer's Society.</gtr:abstractText><gtr:potentialImpactText>== Users and beneficiaries outside academia
These include the NHS (General Practitioners and hospital services) ; opticians; society in general; individual patients and their families through increased availability of a simple screening tool for brain health. Rapid access to early diagnosis of vascular and brain 'health' via an easily accessible test has the potential to improve health and empower the public. Prevention of dementia, and also of stroke 
and cognitive impairment is a Government priority and methods to identify subjects at high risk of 
future dementia are urgently needed. Preservation of brain has a far better chance of preventing 
cognitive decline and dementia than attempting to reverse the dementia after symptom onset. 
== Towards societal impact
Dementia is estimated to cost ~&amp;pound;16-20 billion in the UK and rising; caring for affected patients 
places an additional drain on carers, and social and health services that is difficult to quantify. 
By the time cognition is measurably affected, it may already be too late. 
Many dementia assessment tools have focused on Alzheimer's Dementia, 
but vascular disease is responsible for up to 45% of dementias and may require tools 
sensitive to vascular changes as well as to the effects on the brain structure and cognition. 
Our integrated approach to assessing vascular and neural components of the retina and of the brain 
offers a superb chance of capturing relevant changes at a time when intervention would have a better chance of working. Keeping even a small proportion of people out of nursing homes or hospital or in work will have a major effect on society as a whole. 
== Towards economic impact
Delaying dementia onset by 5 years could reduce costs by half, saving up to &amp;pound;10 billion a year; 
but even delaying dementia onset by 1 year could save several billions per year to 
society, health services, patients and families individual budgets, and maintain dignity by keeping 
people in their own homes. This mey could be put into developing better 
education, health services, and avoiding the inevitable substantial personal financial losses linked with dementia in a family.
== Public engagement
&amp;quot;Seeing into the brain&amp;quot; from the High Street (retinal imaging by optometrists) has immediate public 
resonance and will be an important message to promote. We have wide experience with 
public engagement: the Knowledge Transfer Officers of Edinburgh 
Neuroscience, Imaging, and in the Centre for Cognitive Ageing and Cognitive 
Epidemiology are all very experienced in public engagement; and the dedicated 
CCACE knowledge exchange officer will be available to assist the project. He has led, for example, science festival events, schools workshops, collaborations with artists, writers, and playrights, and 
led the commercialisation of products for the diagnosis of dementia and delirium. 
The Dundee Revealing Research office will assist via public lectures (e.g., the Dundee Saturday Evening Lectures, now in its 90th year), and several other routes. 
The Alzheimer Society has offered their support for dissemination, including use of their Annual 
Research Conference (see attached letter of support).
== Translation 
Translation is the final stage in our 3-part vision: (1) tools development (this project), (2) large-scale trial, (3) translation. Retinal imaging tools developed in this project will 
need to undergo extensive testing in independent cohorts and populations to determine their true 
applicability (stage 2); both Edinburgh and Dundee undertake large clinical trials and have 
accredited Clinical Trials Units that can manage them. Translation and commercialization (stage 3) will be assisted by the relevant offices at the two universities. The Univ of Dundee Research and Innovation Services, the University of Edinburgh BioQuarter and Edinburgh University's Edinburgh Research provides help on all aspects of commercialization.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-08-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-04-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>922996</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Scottish Microelectronics Centre</gtr:department><gtr:description>NANO</gtr:description><gtr:id>C7D76E43-30A5-4F29-AD1B-DE574C805382</gtr:id><gtr:impact>NANO is a strongly multidisciplinary initiative. Its recent creation has not led to truly collaborative publications, although subgroups of participants have published together several times in visible international journals and refereed conferences.</gtr:impact><gtr:outcomeId>58cabae9620b40.67224015-1</gtr:outcomeId><gtr:partnerContribution>The EPSRC project has been a determinant factor for the creation of NANO, has project work and its dissemination have created the visibility needed to catalyze the NANO consortium.</gtr:partnerContribution><gtr:piContribution>NANO (Northern Alliance for Neurodegerative Ophthalmology) is a consortium bringing together opthalmologists, psychiatrists, retinal image analysis specialists (the VAMPIRE group) and brain science researchers. Participating institutions are the University of Belfast, Dundee and Edinburgh. The aim is to develop cutting-edge interdisciplinary research on retinal and brain biomarker for neurodegenerative conditions, primarily dementia, robustify diagnosis, and estimate risk as early as possible. NANO leverages an array of cohorts and bioresources in which participants are involved, including PREVENT, GoDARTS, UK Biobank and others.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NANO</gtr:description><gtr:id>524D43B0-A506-4705-A2CE-B04119267A28</gtr:id><gtr:impact>NANO is a strongly multidisciplinary initiative. Its recent creation has not led to truly collaborative publications, although subgroups of participants have published together several times in visible international journals and refereed conferences.</gtr:impact><gtr:outcomeId>58cabae9620b40.67224015-2</gtr:outcomeId><gtr:partnerContribution>The EPSRC project has been a determinant factor for the creation of NANO, has project work and its dissemination have created the visibility needed to catalyze the NANO consortium.</gtr:partnerContribution><gtr:piContribution>NANO (Northern Alliance for Neurodegerative Ophthalmology) is a consortium bringing together opthalmologists, psychiatrists, retinal image analysis specialists (the VAMPIRE group) and brain science researchers. Participating institutions are the University of Belfast, Dundee and Edinburgh. The aim is to develop cutting-edge interdisciplinary research on retinal and brain biomarker for neurodegenerative conditions, primarily dementia, robustify diagnosis, and estimate risk as early as possible. NANO leverages an array of cohorts and bioresources in which participants are involved, including PREVENT, GoDARTS, UK Biobank and others.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Genito-Urinary and Prostate Focus Group</gtr:department><gtr:description>QUB contract GoDARTS</gtr:description><gtr:id>AB459241-8A9B-428E-8757-1F4D5ED75B1E</gtr:id><gtr:impact>Just started (March 2016) - no outputs yet</gtr:impact><gtr:outcomeId>56dd5bb651b886.44017225-1</gtr:outcomeId><gtr:partnerContribution>Statistical analysis of data provided; integration of contract work within larger context of large, collaborative MRC project coordinated by QUB.</gtr:partnerContribution><gtr:piContribution>Development and use of the VAMPIRE software platform to measure 8-10,000 retinal images from the GoDARTS bioresources (Dundee) and provision of formatted data for statistical analysis of association with various outcomes and clinical parameters (to be performed by QUB)</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NIDEK talk March 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6BB37C7D-DB13-4CA2-98D6-3812AFA767AF</gtr:id><gtr:impact>Invited speaker at scientific workshop (invitation only) organized by NIDEK Technologies, part of the Japanese NIDEK group. Theme is data and image analysis technologies in retinal and eye healthcare.</gtr:impact><gtr:outcomeId>58caa33492b412.02541795</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.nidektechnologies.it/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ItalianInstituteTalk2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CB49E374-247A-4641-8B75-15040D97DB3B</gtr:id><gtr:impact>I organised an evening dedicated to the eye as a window on body health, ie source of biomarkers for risk prediction of systemic, high-incidence diseases like CVD, diabetes and complications, dementia. Advert published online by the venue (Italian Institute of Culture, Edinburgh):
&amp;quot;The eye is a powerful observatory on our health. A complex network of blood vessels can be inspected directly and inexpensively through the pupil. Can these blood vessels and their changes signal the risk of serious systemic problems, like cardiovascular disease or dementia? Three researchers from the Universities of Edinburgh and Dundee discuss their work in an interdisciplinary conversation across ophthalmology, genetics and computer science.&amp;quot;
SPEAKERS: Dr Alex Doney, University of Dundee (EPSRC project CI); Prof Emanuele Trucco, University of Dundee (EPSRC project PI); Dr Andrew Tatham, NHS and University of Edinburgh.
In collaboration with the Italian Institute of Culture (Edinburgh), the Italian Association of Scientists in the UK (AISUK, http://www.aisuk.org/), and the British Science Association (http://edinburghbsa.weebly.com/).</gtr:impact><gtr:outcomeId>58ca58e191bd93.23046384</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.iicedimburgo.esteri.it/iic_edimburgo/en/gli_eventi/calendario/2016/12/what-does-the-eye-tell-us-about.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MacGillivray invited talk IB</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DB0D363D-607D-40A0-91AE-E046ACD31212</gtr:id><gtr:impact>Invited talk at the Edinburgh International Conference Centre, on Information Biotechnology</gtr:impact><gtr:outcomeId>58cab271bd1e85.21438342</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.investinedinburgh.com/news-events/events/innovationnation-biotechnology/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The eye, the brain, the light and the computer</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>841DDF63-3A0D-43B9-BE7A-EA16257F6932</gtr:id><gtr:impact>March 2012: I created and co-organized the initiative &amp;quot;The light, the eye, the brain and the computer&amp;quot; with RSA Scotland (Royal Society for the encouragement of the Arts, manufacturing and commerce), the Italian Cultural Institute (ICI, Edinburgh) and the School of Computing, Univ of Dundee, which spanned 3 events: at ICI Edinburgh (3 speakers in conversation, specialist of photography, image analysis and phychology), GCU Glasgow (as above) and Inverness (I was the only speaker).</gtr:impact><gtr:outcomeId>56dd688f093c85.84185734</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MICCAI OMIA inv talk 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>67A54CDD-C848-4BF7-A00A-6126234824EB</gtr:id><gtr:impact>Invited talk, workshop on Medical Ophthalmic Image Analysis, part of the Medical Image Computing and Computer-based Intervention (MICCAI) conference, Athens, 2016</gtr:impact><gtr:outcomeId>58cab309790bf9.87633898</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV and radio appearances (retinal vasculature and dementia)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4FBC4CE7-656E-41BD-BA14-7B0833DDFEDB</gtr:id><gtr:impact>The EPSRC EP/M005976/1 project &amp;quot;Multi-modal retinal biomarkers for vascular dementia&amp;quot;, on which I am PI, was announced on Mon 27th Oct 2014 by all major newspapers in England and Scotland (incl Times, Times Higher Education, Guardian, Independent, Daily Mail, Daily Record, Courier, Huffington Post, Herald, Evening Telegraph), abroad (incl Times of India, ECanada News), radio stations (BBC R5 Live Breakfast, BBC Scotland, West Midlands, Gloucestershire, Heretfordshire) and several television (BBC Reporting Scotland, STV). I appeared on several TV and radio interviews.</gtr:impact><gtr:outcomeId>56dd67a71a4771.47702467</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LABEL MICCAI inv talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>64AC11C6-4018-4760-9D94-515655C5433A</gtr:id><gtr:impact>Invited talk, workshop on Large-Scale Annotation of Biomedical data and Expert-Level Synthesis (LABEL), part of the int conf on Medical Image Computing and Computer-Based Intervention (MICCAI) 2017, Quebec City.</gtr:impact><gtr:outcomeId>58cab3a49a2332.97128022</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>160000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Subcontract QUB-MRC</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Queen's University Belfast</gtr:fundingOrg><gtr:id>6A291E81-DA78-49FC-87E9-53C9E2FB6DA1</gtr:id><gtr:outcomeId>58ca56f236cad6.98380332</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC VAMPIRE Web app</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>09EF51F4-A457-4C61-B403-62911612BE6C</gtr:id><gtr:outcomeId>58cab4a8e965f9.28706401</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>In the first year of the EPSRC project, CI Doney and the research nurse employed (R Bittern) accessed the Ninewells patient data archives to validate dementia diagnosis, resulting in a large (by current standard: n=1,232 with dementia) cross-linked data set. All patients feature in the GoDARTS bioresource (http://diabetesgenetics.dundee.ac.uk/, n &amp;gt; 116,000 of which &amp;gt;9,400 diabetics). We have now a unique resource including retinal images, OCT, physiological data, prescriptions, radiological images for a subset of patients, many of which longitudinal (eg retinal images exist for several time points thank to the local diabetic retinopathy screening program). The bioresource is being used for the main questions in the EPSRC project (associations btw markers in the retina, in the brain, and dementia).</gtr:description><gtr:id>B6463B73-FE7A-4CEC-B39F-647E9DB8D42A</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>58ca720f1e23c0.81320809</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dementia Bioresource</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>VAMPIRE (Vessel Assessment and Measurement Platform for Images of the REtina) is an international initiative led by EPSRC PI Trucco (Univ of Dundee) and EPSRC CI MacGillivray (Univ of Edinburgh). The flagship software package, VAMPIRE 3.1 (current version), is a semi-automatic package developed by Dundee and Edinburgh since the early 2000s, generating currently 130 measurements quantifying the morphometry of the eye microvasculature. VAMPIRE software allows efficient processing (measuring) of large quantities of images; for a trained operator following the standard batch-mode protocol, an image is analysed in about 4'. Measurements includes standard ones as defined in the literature (AVR, CRAE, CRVE, tortuosity).
The EPSRC project has allowed us to move from VAMPIRE 2.0 to VAMPIRE 3.1, adding significantly innovative features like improved artery-vein classification, segmentation of vascular trees emanating from the optic disc, and speed-up of key modules (eg A-V classification).</gtr:description><gtr:id>6673901C-45B1-434A-8AF4-3BCDDF941C18</gtr:id><gtr:impact>VAMPIRE 3.1 is not commercially available, but has achieved international visibility and has been made available to clinical research groups in the UK (Queen's University Belfast) and France (Univ of Lyon) after a 3-day training program. Further clinical groups have asked for VAMPIRE measurements of images made available to us (eg from the University of Malaysia, Great Ormond Street Hospital, Institut Oftalmologia Clinica Girona, and others). In addition, a publicly available annotation tools for fundus retinal images is available on the VAMPIRE website (vampire.computing.dundee.ac.uk).</gtr:impact><gtr:outcomeId>58ca80e6b5cda7.34554556</gtr:outcomeId><gtr:title>VAMPIRE 3.1</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>728B20AC-091A-4411-A512-E313FB6FE2BD</gtr:id><gtr:title>Perivascular Spaces Segmentation in Brain MRI Using Optimal 3D Filtering.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f81935f66a605677fc3e3aecad7d69d5"><gtr:id>f81935f66a605677fc3e3aecad7d69d5</gtr:id><gtr:otherNames>Ballerini L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa14964768df9.02258593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A96BA191-040B-45D7-9F53-A193FF44859F</gtr:id><gtr:title>The application of retinal fundus camera imaging in dementia: A systematic review.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e7cfc8b5b1f8101ff23e0d6634bf694"><gtr:id>7e7cfc8b5b1f8101ff23e0d6634bf694</gtr:id><gtr:otherNames>McGrory S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c2e2118a7d59.25538946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A065CAA4-6C9D-4B58-84A1-38E829FA5B25</gtr:id><gtr:title>Determinants of retinal microvascular features and their relationships in two European populations.</gtr:title><gtr:parentPublicationTitle>Journal of hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82dd55645e2fe37f25972e31d93f06a0"><gtr:id>82dd55645e2fe37f25972e31d93f06a0</gtr:id><gtr:otherNames>Kirin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0263-6352</gtr:issn><gtr:outcomeId>5aa15059eadc94.06996443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A0FFD3F-4B9A-4D78-985A-49ECEF70B603</gtr:id><gtr:title>Lateral thinking - Interocular symmetry and asymmetry in neurovascular patterning, in health and disease.</gtr:title><gtr:parentPublicationTitle>Progress in retinal and eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccff4e84a3e63412869b556c59db3662"><gtr:id>ccff4e84a3e63412869b556c59db3662</gtr:id><gtr:otherNames>Cameron JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9462</gtr:issn><gtr:outcomeId>5aa15058dc8460.44085048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3FE275F-F3EF-401A-A070-A413083FB4E7</gtr:id><gtr:title>Sub-Category Classifiers for Multiple-Instance Learning and its Application to Retinal Nerve Fiber Layer Visibility Classification.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aadedf28cf171d244e183c8b62e98495"><gtr:id>aadedf28cf171d244e183c8b62e98495</gtr:id><gtr:otherNames>Manivannan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn><gtr:outcomeId>58c2e2114bfd56.53462162</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FED54FD1-5955-48BC-9A76-7BD62BFAF864</gtr:id><gtr:title>Retinal microvascular network geometry and cognitive abilities in community-dwelling older people: The Lothian Birth Cohort 1936 study.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e7cfc8b5b1f8101ff23e0d6634bf694"><gtr:id>7e7cfc8b5b1f8101ff23e0d6634bf694</gtr:id><gtr:otherNames>McGrory S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>585d445110ee74.09028359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0A6DA20-A08E-4456-9B29-00F393A5472D</gtr:id><gtr:title>Evaluation of coronary artery disease as a risk factor for reticular pseudodrusen.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81cb50b756f1ed643f2565a8a68f2bb2"><gtr:id>81cb50b756f1ed643f2565a8a68f2bb2</gtr:id><gtr:otherNames>McCarter RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>5aa1505a22eaa8.41626722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3597D736-4366-4EC9-97A9-1313F9E4D909</gtr:id><gtr:title>Learning discriminative local features from image-level labelled data for colonoscopy image classification</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aadedf28cf171d244e183c8b62e98495"><gtr:id>aadedf28cf171d244e183c8b62e98495</gtr:id><gtr:otherNames>Manivannan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>19458452</gtr:issn><gtr:outcomeId>56dd6b6a4b98c0.82367181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66236EB1-54E0-4D27-96BB-0175CEE9278E</gtr:id><gtr:title>Structure Prediction for Gland Segmentation With Hand-Crafted and Deep Convolutional Features.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aadedf28cf171d244e183c8b62e98495"><gtr:id>aadedf28cf171d244e183c8b62e98495</gtr:id><gtr:otherNames>Manivannan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn><gtr:outcomeId>5a67015851f514.04085297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56F59419-35E2-42A8-B349-6F20895250F4</gtr:id><gtr:title>Novel Locus Influencing Retinal Venular Tortuosity Is Also Associated With Risk Of Coronary Artery Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22fa28ed03263e8cbfe07f73011ced93"><gtr:id>22fa28ed03263e8cbfe07f73011ced93</gtr:id><gtr:otherNames>Veluchamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa14aac95d604.34191934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0B383B7-A71D-416F-A62E-B56E9E640FE8</gtr:id><gtr:title>A Graph Cut Approach to Artery/Vein Classification in Ultra-Widefield Scanning Laser Ophthalmoscopy.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b1ca2dcf25252ca0e7a5d88443a2687"><gtr:id>1b1ca2dcf25252ca0e7a5d88443a2687</gtr:id><gtr:otherNames>Pellegrini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn><gtr:outcomeId>5aa1505a47a2b8.05613885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6CE6AB-8451-44D1-AD11-986CBF68F071</gtr:id><gtr:title>Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fda84a7ba99b14ed43b54e15000f025"><gtr:id>0fda84a7ba99b14ed43b54e15000f025</gtr:id><gtr:otherNames>Paterson EN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5aa150a58f6183.09122480</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/M005976/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A759BB04-AFFE-4780-BD31-9A2707BC44BA</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Medical Imaging</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>